Experts Aim to Improve Chest Pain Patient Outcomes
Leading experts will discuss and debate the most up-to-date cardiovascular disease data
and treatment options at a satellite symposium co-sponsored by Medavera, Inc. and held during
the 12th Annual Congress of the Society of Chest Pain Centers.
Springfield, MO (PRWEB) April 9, 2009 - Medavera, Inc., a leading provider of medical education services, today announced, Heart Cases: Discussions & Decisions in Chest Pain Management. Designed to improve acute chest pain evaluation, diagnosis, and care, the program of expert presentations and panels will convene April 30, 2009, at the Peabody Hotel in Memphis, TN, in parallel with the 12th Annual Congress of the Society of Chest Pain Centers, an organization dedicated to improving cardiac patient outcomes, including via center accreditation.
Coronary artery disease remains the leading cause of death in the U.S. and acute coronary syndrome (ACS) demands a large share of emergency resources. Patients with chest pain and suspected cardiac ischemia must be managed more promptly and properly. Driven by the cause and effect between educational accreditation and heightened performance, program participants will review the most current clinical data and guidelines for cardiac patients.
Robert Weisenburger Lipetz, Executive Director of the Society of Chest Pain Centers, said, "Facility accreditation and caregiver education are vital components of our mission to promote best practices in the world of cardiac care. The 12th Congress of Chest Pain Centers is an excellent resource for advanced care information."
Topics covered in the Heart Cases satellite program include the use of therapeutic hypothermia in post sudden cardiac arrest, high-sensitivity troponin in chest pain risk stratification, new therapies for platelet inhibition and measuring platelet reactivity, body-surface mapping over traditional electrocardiogram (EKG), and antithrombotics in non-ST-elevation myocardial infarction (MI) patients.
Novel technologies and strategies are helping to change the paradigm in hospital care. Regarding his presentation, program co-chair W. Frank Peacock IV, MD, Vice Chair of the Cleveland Clinic Emergency Medicine Institute, said, "The BEACON registry is structured to evaluate the workup of those patients not yet diagnosed. By analyzing what works, what's efficient, and what's not, we can speed and improve evaluation of prospective ACS patients. One of the potential benefits from BEACON will be in understanding the impact of EKG mapping in identifying occult myocardial infarction. BEACON also will permit us to formulate new approaches to multimarker, coronary CAT scan, and other diagnostic tests."
Biomarkers are continuing to enable heightened coronary patient prognosis. Regarding his presentation, program faculty member James K. McCord, MD, President of the Society of Chest Pain Centers and Cardiology Director, Inpatient Services, Henry Ford Hospital, said, "The new high-sensitivity troponin assays will enable high-risk ACS patients to be identified more quickly and low-risk patients to have MI excluded more rapidly. The 'rule-out' MI process that presently occurs in six to nine hours may be lowered to three hours or less."
Program co-chair Cynthia G. Waller, RN, MSN, PhD(c), Clinical Instructor, Vanderbilt University School of Nursing, and former Cardiac Administrator for HCA, TriStar Health System, said "It's imperative that nursing and administrative staff, too, remain informed and responsive to clinical evidence and protocols to improve the care and treatment of cardiac patients. Heart Cases is a unique opportunity to fulfill this imperative."
Additional expert faculty include: Deborah B. Diercks, MD, MSc, Professor and Director of Research, Department of Emergency Medicine, University of California, Davis Medical Center; James A. de Lemos, MD, J. Fred Schoellkopf, Jr. Chair in Cardiology and Director, Coronary Care Unit, Parkland Memorial Hospital, and also the Director, Cardiology Fellowship Training Program, UT Southwestern Medical Center; and Brian J. O'Neil, MD, Edward S. Thomas Endowed Professor, Associate Chair of Research and Director of Basic Science Research, Department of Emergency Medicine, Wayne State University.
Laura McCaskill, President & CEO, Medavera, Inc., program co-sponsor, said "Heart Cases is a prime example of our leading medical education programs. By bringing together experts in the field, teachers and practitioners, we support caregivers in their call to improve the quality of patient care and regulatory compliance."
Heart Cases will begin at 6:30 pm on April 30, 2009 in the Grand Ballroom of the Peabody Hotel. Medavera, Inc. and the University of Massachusetts Medical School are presenting the program, in accordance with the Accreditation Council for Continuing Medical Education. Accumetrics, Heartscape Technologies, Nanosphere, sanofi aventis, and ZOLL Medical Corporation have provided educational support.
A panel discussion with question-and-answer session will follow each presentation. Attendees will receive a meeting syllabus, a CD of teaching materials, and future access to an accredited webcast and full-program transcript. For more information about attending the 12th Annual Meeting of the Society of Chest Pain Centers, visit www.scpcp.org.
About Medavera
Medavera, Inc. is a medical education company headquartered in Springfield, MO. The company mission is to improve patient health by identifying educational need and transferring medical knowledge with superior communication strategies and tools. For more information, please visit www.medavera.com.
###
Post Comment:
Trackback URL: http://www.prweb.com/pingpr.php/VGhpci1IYWxmLU1hZ24tU3F1YS1QaWdnLUNvdXAtWmVybw==
Bookmark -
Del.icio.us |
Furl It |
Technorati |
Ask |
MyWeb |
Propeller |
Live Bookmarks |
Newsvine |
TailRank |
Reddit |
Slashdot |
Digg |
Stumbleupon |
Google Bookmarks |
Sphere |
Blink It |
Spurl
|
